Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    Chondrosarcoma Awareness Day is One Week Away.

    January 30th, 2021One week from today is Chondrosarcoma Awareness Day. Thank you for going on our web site and signing on to support our petition for Chondrosarcoma Research and Clinical Trials. The Chondrosarcoma Foundation is initiating an international public...

    Read Article

    A medication to treat Soft Tissue Sarcomas gets FDA approval

    January 30th, 2021Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug...

    Read Article

    A clinical trial for treating Metastatic Convention Chondrosarcoma

    January 30th, 2021Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in...

    Read Article

    Chondrosarcoma Awareness Day is in 11 days

    January 27th, 2021We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following: 1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue...

    Read Article

    Getting Media Attention: Chondrosarcoma CS Foundation, Inc. Initiates Worldwide Campaign to Proclaim February 6, 2021 As Chondrosarcoma Awareness Day

    January 24th, 2021The Chondrosarcoma Awareness Day is getting the attention from many media outlets across the globe. We are doing our best to raise awareness and support for Chondrosarcoma research and clinical trials. Please check out the links...

    Read Article

    Chondrosarcoma CS Foundation, Inc. Initiates Worldwide Campaign to Proclaim February 6, 2021 As Chondrosarcoma Awareness Day

    January 21st, 2021The Bowie, MD-based Chondrosarcoma CS Foundation, Inc. is launching an international public campaign to raise awareness and support for Chondrosarcoma research and clinical trials. They are proclaiming February 6, 2021, as Chondrosarcoma Awareness...

    Read Article

    Another Potential Medication for Metastatic Chondrosarcoma

    January 18th, 2021Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year SAN DIEGO,...

    Read Article

    Another Potential Medication for Metastatic Conventional Chondrosarcoma

    January 18th, 2021Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year Inhibrx, Inc....

    Read Article